CapsoVisionCV
CV logo
Fair Value
US$10.5
Share price25 Jan
US$6.4638.5% undervalued intrinsic discount
Loading
1Y67.79%
7D-9.01%

Cloud And AI Capsule Endoscopy Will Reshape Long Term Prospects For This Undervalued GI Player

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
25 Jan 26
Views
16
Not Invested

Fair Value vs Share Price

US$10.5
vs US$6.4638.5% undervalued intrinsic discount
PastFuture-21m124m2023202420252026202720282029Revenue US$124.4mEarnings US$7.3m
111.8%
Revenue growth
5.8%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on CapsoVision

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Flawless balance sheet with minimal risk.

Market capUS$339.8m
PB16.0x
Estimated GrowthN/A
Dividend YieldN/A
Full analysis

CEO & management

Kang-Huai Wang
CEO
9.8yrs
CEO Tenure

A medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system.